ANDERSON DOE PODIATRY CLINIC LIMITED
Opportunity 77/100 (strong), bankability 75/100. Strong seller-intent signal (60/100, director aged 68). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £13.1k | £6.6k |
| Current assets | £30.2k | £33.1k |
| Net assets | £13.1k | £6.6k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
Corporate timeline (12 events)Click to expand
- 2025-11-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-06-14📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-09-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-08-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-11-03📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-09-28📄change-person-director-company-with-change-dateofficers · CH01
- 2020-10-07📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-08-06📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2019-09-09🏢Company incorporatedAs ANDERSON DOE PODIATRY CLINIC LIMITED
- 2019-09-09➕BROMFIELD, Susan Belle appointeddirector
- 2019-09-09➕CAMPBELL, Jill appointeddirector
- 2019-09-09📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Founder age: Director aged approximately 68 — succession pressure is live.
- +No director turnover: Company is 7 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 68. Approaching typical UK retirement age — succession thinking likely.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Miss Sue Bromfield Individual · British · DOB 07/1958 · age 68 | 25–50% | — | 25-50% shares | 09/09/2019 |
Mrs Jill Campbell Individual · British · DOB 03/1964 · age 62 | 25–50% | — | 25-50% shares | 09/09/2019 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AM NURSERY GROUP LIMITED→ SC768675 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AMARANTHINE AESTHETICS & WELLBEING LTD→ SC677484 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AMD MAPLE LIMITED→ SC797976 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AMIRS HEALTHCARE LIMITED→ SC633331 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AMZPHARM LTD→ SC698191 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AN KANG LTD→ SC842040 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ANDREW BIANKIN LTD→ SC500006 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| ANGELA HECHT THERAPY LTD→ SC714674 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ANGELIKI PAPADOPOULOU LTD→ SC755723 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ANK ASSOCIATES & CO LTD→ SC852003 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ANNE MORRISON HEALTH LTD→ SC854383 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ANNE PENMAN LIMITED→ SC260304 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.